P-38 KEYNOTE-859: A randomized, double-blind, placebo-controlled phase 3 trial of first-line pembrolizumab plus chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma
| Autor: | Tabernero, J., Bang, Y., Cutsem, E. Van, Fuchs, C., Janjigian, Y., Bhagia, P., Li, K., Adelberg, D., Qin, S. |
|---|---|
| Zdroj: | In Annals of Oncology July 2020 31 Supplement 3:S101-S102 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|